New Binding Sites, New Opportunities for GPCR Drug Discovery

Trends Biochem Sci. 2019 Apr;44(4):312-330. doi: 10.1016/j.tibs.2018.11.011. Epub 2019 Jan 3.

Abstract

Many central biological events rely on protein-ligand interactions. The identification and characterization of protein-binding sites for ligands are crucial for the understanding of functions of both endogenous ligands and synthetic drug molecules. G protein-coupled receptors (GPCRs) typically detect extracellular signal molecules on the cell surface and transfer these chemical signals across the membrane, inducing downstream cellular responses via G proteins or β-arrestin. GPCRs mediate many central physiological processes, making them important targets for modern drug discovery. Here, we focus on the most recent breakthroughs in finding new binding sites and binding modes of GPCRs and their potentials for the development of new medicines.

Keywords: GPCR; binding sites; drug discovery; drug targets; protein–ligand interactions.

Publication types

  • Review

MeSH terms

  • Binding Sites / drug effects
  • Drug Discovery*
  • Humans
  • Ligands
  • Pharmaceutical Preparations
  • Receptors, G-Protein-Coupled / antagonists & inhibitors*
  • Receptors, G-Protein-Coupled / metabolism

Substances

  • Ligands
  • Pharmaceutical Preparations
  • Receptors, G-Protein-Coupled